This article was originally published in The Tan Sheet
FDA is sponsoring a Nov. 9-10 public hearing on how best to implement a surveillance system to track bacterial resistance to human and animal antimicrobial agents. FDA's Anti-Infective Drugs and Veterinary Medicine Advisory Committees have previously recommended improved surveillance through a cooperative effort involving government, academia and industry. The hearing will take place at the Rockville Civic Center, 603 Edmonston Drive, in Rockville, Md. beginning at 8:30 a.m. each day. For further information, call 301/309-3007
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC